Published in Bull World Health Organ on January 01, 1999
Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection. Clin Infect Dis (2002) 1.59
European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index. J Clin Microbiol (2005) 1.53
LDBio-Toxo II immunoglobulin G Western blot confirmatory test for anti-toxoplasma antibody detection. J Clin Microbiol (2008) 1.15
Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasit Vectors (2015) 1.06
Discrepancies between a new highly sensitive Toxoplasma gondii ELISA assay and other reagents: interest of Toxo IgG Western blot. Eur J Clin Microbiol Infect Dis (2011) 0.99
Identification of potential serodiagnostic and subunit vaccine antigens by antibody profiling of toxoplasmosis cases in Turkey. Mol Cell Proteomics (2011) 0.98
Utility of immunoblotting for early diagnosis of toxoplasmosis seroconversion in pregnant women. Clin Vaccine Immunol (2011) 0.95
Bicentric evaluation of six anti-toxoplasma immunoglobulin G (IgG) automated immunoassays and comparison to the Toxo II IgG Western blot. Clin Vaccine Immunol (2009) 0.92
Evaluation of a candidate international standard preparation for human anti-Toxoplasma immunoglobulin G. J Clin Microbiol (2004) 0.92
Serologic evidence that ascaris and toxoplasma infections impact inflammatory responses to Helicobacter pylori in Colombians. Helicobacter (2012) 0.85
A new IgG immunoblot kit for diagnosis of toxoplasmosis in pregnant women. Korean J Parasitol (2014) 0.82
Multiplexed Anti-Toxoplasma IgG, IgM, and IgA Assay on Plasmonic Gold Chips: towards Making Mass Screening Possible with Dye Test Precision. J Clin Microbiol (2016) 0.82
Simple and efficient method for measuring anti-toxoplasma immunoglobulin antibodies in human sera using complement-mediated lysis of transgenic tachyzoites expressing beta-galactosidase. J Clin Microbiol (2001) 0.81
IgG western blot for confirmatory diagnosis of equivocal cases of toxoplasmosis by EIA-IgG and fluorescent antibody test. Korean J Parasitol (2013) 0.77
Evaluation of the liaison automated testing system for diagnosis of congenital toxoplasmosis. Clin Vaccine Immunol (2012) 0.77
Evaluation of the Vitros ECiQ immunodiagnostic system for detection of anti-Toxoplasma immunoglobulin G and immunoglobulin M antibodies for confirmatory testing for acute Toxoplasma gondii infection in pregnant women. J Clin Microbiol (2008) 0.77
Help in the Choice of Automated or Semiautomated Immunoassays for Serological Diagnosis of Toxoplasmosis: Evaluation of Nine Immunoassays by the French National Reference Center for Toxoplasmosis. J Clin Microbiol (2016) 0.75
Multicenter evaluation of the Elecsys Toxo IgG and IgM tests for the diagnosis of infection with Toxoplasma gondii. Eur J Microbiol Immunol (Bp) (2015) 0.75
Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood (1997) 4.36
Are eukaryotic microorganisms clonal or sexual? A population genetics vantage. Proc Natl Acad Sci U S A (1991) 4.30
Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man. J Clin Invest (1973) 3.34
Raised serum levels of tumour necrosis factor in parasitic infections. Lancet (1986) 3.23
Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med (1988) 3.15
Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr (1989) 2.98
Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet (1999) 2.97
Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med (1994) 2.94
Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group . Lancet (1999) 2.54
Genetic diversity, clonality and sexuality in Toxoplasma gondii. Int J Parasitol (2004) 2.54
IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J Infect Dis (1990) 2.49
Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur J Clin Microbiol Infect Dis (1996) 2.43
Prenatal diagnosis of congenital toxoplasmosis. Lancet (1985) 2.43
Immunochemical analysis of plasmid-encoded proteins released by enteropathogenic Yersinia sp. grown in calcium-deficient media. Infect Immun (1986) 2.42
Retrospective analysis of 49 cases of brain abscess and review of the literature. Eur J Clin Microbiol Infect Dis (2007) 2.39
Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Microbiol Infect (2010) 2.32
Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infect Immun (1994) 2.26
Activation of the c-mos oncogene in a mouse plasmacytoma by insertion of an endogenous intracisternal A-particle genome. Proc Natl Acad Sci U S A (1983) 2.23
Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii. J Clin Microbiol (1990) 2.19
Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana. J Clin Microbiol (2002) 2.18
Malaria chemoprophylaxis: why mefloquine? Lancet (1990) 2.13
The Thucydides syndrome. A new hypothesis for the cause of the plague of Athens. N Engl J Med (1985) 2.04
Risk factors for Toxoplasma gondii infection in pregnancy. Results of a prospective case-control study in Norway. Am J Epidemiol (1996) 2.04
Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral Leishmaniasis in immunocompromised patients. J Clin Microbiol (1994) 2.04
Radical surgical therapy of abdominal cystic hydatid disease: factors of recurrence. World J Surg (2000) 2.03
Risk factors for Toxoplasma infection in pregnancy: a case-control study in France. Scand J Infect Dis (1999) 2.01
Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid. J Clin Microbiol (1990) 1.95
Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol (1999) 1.92
MRI-guided STN DBS in Parkinson's disease without microelectrode recording: efficacy and safety. J Neurol Neurosurg Psychiatry (2010) 1.84
Paternal age effect in Down's syndrome. Ann Hum Genet (1977) 1.84
Correlations between morphological, molecular biological, and physiological characteristics in clinical and nonclinical isolates of Acanthamoeba spp. Appl Environ Microbiol (2000) 1.84
Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. Pediatrics (2001) 1.80
Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patients. Thorax (2005) 1.78
Bone marrow cellularity assessed by point-counting. J Clin Pathol (1978) 1.75
Cloning and characterization of a bradyzoite-specifically expressed gene (hsp30/bag1) of Toxoplasma gondii, related to genes encoding small heat-shock proteins of plants. Mol Microbiol (1995) 1.75
Biological and genetic characterisation of Toxoplasma gondii isolates from chickens (Gallus domesticus) from São Paulo, Brazil: unexpected findings. Int J Parasitol (2002) 1.74
Dissection of the human antibody response to the malaria antigen Pf155/RESA into epitope specific components. Immunol Rev (1989) 1.73
Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages. Infect Immun (1993) 1.72
Incidence study of Down's syndrome in Copenhagen, 1960-1971; with chromosome investigation. Ann Hum Genet (1976) 1.72
Application of the polymerase chain reaction in the diagnosis of pulmonary toxoplasmosis in immunocompromised patients. Eur J Clin Microbiol Infect Dis (1992) 1.71
Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle. Mol Biochem Parasitol (1991) 1.70
Seasonal density, sporozoite rates and entomological inoculation rates of Anopheles gambiae and Anopheles funestus in a high-altitude sugarcane growing zone in Western Kenya. Trop Med Int Health (1998) 1.68
Role of specific immunoglobulin E in diagnosis of acute toxoplasma infection and toxoplasmosis. J Clin Microbiol (1993) 1.68
In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrob Agents Chemother (1997) 1.67
Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines. Bone Marrow Transplant (2001) 1.66
Assessment of rapid ELISA test for detection of Epstein-Barr virus infection. J Clin Pathol (1990) 1.66
Pathology of malaria-infected mosquitoes. Parasitol Today (1987) 1.63
Prevalence of antibodies to Neospora caninum in horses in France. Equine Vet J (2001) 1.61
A clinical study of chronic fatigue syndrome. Br J Psychiatry (1995) 1.57
The relationship between atypical lymphocytosis and serological tests in infectious mononucleosis. J Infect (1981) 1.57
Severe toxoplasmosis caused by a Toxoplasma gondii strain with a new isoenzyme type acquired in French Guyana. J Clin Microbiol (1998) 1.55
Borrelia burgdorferi-associated cutaneous marginal zone lymphoma: a clinicopathological study of two cases illustrating the temporal progression of B. burgdorferi-associated B-cell proliferation in the skin. Histopathology (2000) 1.55
Discrimination between clinically relevant and nonrelevant Acanthamoeba strains isolated from contact lens- wearing keratitis patients in Austria. J Clin Microbiol (2000) 1.53
Congenital toxoplasmosis: to screen or not to screen? Public Health (1990) 1.52
Liver lipid metabolism. J Anim Physiol Anim Nutr (Berl) (2008) 1.52
Simultaneous serological screening for congenital cytomegalovirus and toxoplasma infection. Public Health (1988) 1.51
Systematic serologic screening for toxoplasmosis in pregnancy. Obstet Gynecol (1993) 1.50
[Imported pediatric malaria in Marseille]. Arch Pediatr (1999) 1.50
[Congenital toxoplasmosis. Transitory negative serology]. Presse Med (2001) 1.50
The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002. Arch Dis Child (2006) 1.49
Dynamic sonography with provocation of pain for diagnosis of symptomatic mobile kidneys. Eur J Surg (2001) 1.46
Hydroxyl radical generation in oxygen-treated infants. Pediatrics (1997) 1.46
Reevaluation of total-lymphoid irradiation and cyclosporine therapy in the Syrian hamster-to-Lewis rat cardiac xenograft model. Transplantation (1990) 1.45
Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol (2001) 1.44
Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology (2010) 1.44
Persistence of tissue cysts in edible tissues of cattle fed Toxoplasma gondii oocysts. Am J Vet Res (1993) 1.44
Quantitative bacterial examination of domestic water supplies in the Lesotho Highlands: water quality, sanitation, and village health. Bull World Health Organ (1999) 1.43
Infectivity of low numbers of Toxoplasma gondii oocysts to pigs. J Parasitol (1996) 1.43
Isolation and characterization of a repetitive DNA sequence from Leishmania infantum: development of a visceral leishmaniasis polymerase chain reaction. Am J Trop Med Hyg (1993) 1.43
Fetal toxoplasmosis: ultrasonographic signs. Ultrasound Obstet Gynecol (1991) 1.42
Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill (2010) 1.42
A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia. Nature (1987) 1.42
Recombinant Toxoplasma gondii surface antigen 1 (P30) expressed in Escherichia coli is recognized by human Toxoplasma-specific immunoglobulin M (IgM) and IgG antibodies. Clin Diagn Lab Immunol (1996) 1.41
Value of PCR for evaluating occurrence of parasitemia in immunocompromised patients with cerebral and extracerebral toxoplasmosis. J Clin Microbiol (1994) 1.41
Bilateral papillitis in ocular toxoplasmosis. Eye (Lond) (2009) 1.39
Role of small round viruses and small round structured viruses. Lancet (1994) 1.38
Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation (1994) 1.37
Usefulness of Toxoplasma gondii-specific recombinant antigens in serodiagnosis of human toxoplasmosis. J Clin Microbiol (2004) 1.37
Infestation of rodents with larval Ixodes ricinus (Acari: Ixodidae) is an important factor in the transmission cycle of Borrelia burgdorferi s.l. in German woodlands. J Med Entomol (1995) 1.36
Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol (2001) 1.35
Toxoplasma antigens recognized by immunoglobulin G subclasses during acute and chronic infection. J Clin Microbiol (1989) 1.34
Genetic contribution of the HLA region to the familial clustering of coeliac disease. Ann Hum Genet (1997) 1.34
Epidemiological trend of human leptospirosis in Italy between 1994 and 1996. Eur J Epidemiol (2000) 1.34
Sensitivity and specificity of various serologic tests for detection of Toxoplasma gondii infection in naturally infected sows. Am J Vet Res (1995) 1.32
Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology (1997) 1.31
Toxoplasma gondii in Iowa sows: comparison of antibody titers to isolation of T. gondii by bioassays in mice and cats. J Parasitol (1995) 1.30
[A new agglutination reaction for the diagnosis of the developmental stage of acquired toxoplasmosis]. Pathol Biol (Paris) (1986) 1.30
Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha. Eur J Immunol (2001) 1.30
Antibodies to a recombinant glutamate-rich Plasmodium falciparum protein: evidence for protection of individuals living in a holoendemic area of Liberia. Am J Trop Med Hyg (1992) 1.29
Rapid identification of causative species in patients with Old World leishmaniasis. J Clin Microbiol (1997) 1.29
The use of an IgM immunosorbent agglutination assay to diagnose congenital toxoplasmosis. J Med Microbiol (1989) 1.28
Recombinant Plasmodium falciparum glutamate rich protein; purification and use in enzyme-linked immunosorbent assay. Am J Trop Med Hyg (1991) 1.28